Header Logo

Connection

Andrew Ambrosy to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Andrew Ambrosy has written about Treatment Outcome.
Andrew Ambrosy
Connection Strength
1.781
Treatment Outcome
  1. Angiotensin receptor-neprilysin inhibitor therapy in heart failure: An end that justifies the means. Am Heart J. 2018 05; 199:176-177.
    View in: PubMed
    Score: 0.120
  2. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. Am Heart J. 2018 05; 199:97-104.
    View in: PubMed
    Score: 0.119
  3. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial. Am Heart J. 2017 Apr; 186:130-138.
    View in: PubMed
    Score: 0.111
  4. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. JACC Heart Fail. 2017 01; 5(1):1-13.
    View in: PubMed
    Score: 0.111
  5. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Circ Heart Fail. 2016 05; 9(5).
    View in: PubMed
    Score: 0.106
  6. The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions. J Am Coll Cardiol. 2014 May 13; 63(18):1823-32.
    View in: PubMed
    Score: 0.091
  7. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013 Mar; 34(11):835-43.
    View in: PubMed
    Score: 0.084
  8. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial. Am Heart J. 2013 Feb; 165(2):216-25.
    View in: PubMed
    Score: 0.084
  9. Capecitabine-induced chest pain relieved by diltiazem. Am J Cardiol. 2012 Dec 01; 110(11):1623-6.
    View in: PubMed
    Score: 0.082
  10. Acute heart failure syndromes: assessment and reconstructing the heart. J Cardiovasc Med (Hagerstown). 2011 Apr; 12(4):258-63.
    View in: PubMed
    Score: 0.074
  11. Tolvaptan for the treatment of heart failure: a review of the literature. Expert Opin Pharmacother. 2011 Apr; 12(6):961-76.
    View in: PubMed
    Score: 0.074
  12. Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis. Am Heart J. 2023 02; 256:60-72.
    View in: PubMed
    Score: 0.041
  13. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Feb 05; 22(1):115.
    View in: PubMed
    Score: 0.037
  14. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation. JACC Cardiovasc Interv. 2020 10 26; 13(20):2331-2341.
    View in: PubMed
    Score: 0.036
  15. Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial. Circ Heart Fail. 2020 05; 13(5):e006758.
    View in: PubMed
    Score: 0.035
  16. The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF. Eur J Heart Fail. 2020 06; 22(6):1022-1031.
    View in: PubMed
    Score: 0.035
  17. Spontaneous Coronary Artery Dissection and Incident Ventricular Arrhythmias: Frequency, Clinical Characteristics, and Outcomes. JACC Cardiovasc Interv. 2020 02 24; 13(4):539-541.
    View in: PubMed
    Score: 0.034
  18. Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. Can J Cardiol. 2019 09; 35(9):1097-1105.
    View in: PubMed
    Score: 0.032
  19. Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial. Eur J Heart Fail. 2018 12; 20(12):1760-1763.
    View in: PubMed
    Score: 0.031
  20. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9.
    View in: PubMed
    Score: 0.031
  21. Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial. ESC Heart Fail. 2018 12; 5(6):1035-1043.
    View in: PubMed
    Score: 0.031
  22. Improving Postdischarge Outcomes in Acute Heart Failure. Am J Ther. 2018 Jul/Aug; 25(4):e475-e486.
    View in: PubMed
    Score: 0.031
  23. Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. Am Heart J. 2018 04; 198:145-151.
    View in: PubMed
    Score: 0.030
  24. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2018 02; 20(2):304-314.
    View in: PubMed
    Score: 0.029
  25. Global Variations in Patient Populations and Outcomes in Heart Failure Clinical Trials. Curr Heart Fail Rep. 2017 02; 14(1):30-39.
    View in: PubMed
    Score: 0.028
  26. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Circ Heart Fail. 2016 09; 9(9).
    View in: PubMed
    Score: 0.027
  27. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial. JACC Heart Fail. 2016 07; 4(7):580-588.
    View in: PubMed
    Score: 0.026
  28. Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. Am J Cardiol. 2016 Apr 01; 117(7):1144-50.
    View in: PubMed
    Score: 0.026
  29. Lipids, statins, and clinical outcomes in heart failure: rethinking the data. Heart Fail Rev. 2014 Nov; 19(6):695-8.
    View in: PubMed
    Score: 0.024
  30. Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial). Am J Cardiol. 2014 Dec 01; 114(11):1713-21.
    View in: PubMed
    Score: 0.024
  31. Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. Am Heart J. 2014 Aug; 168(2):142-9.
    View in: PubMed
    Score: 0.023
  32. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013 Mar; 18(2):107-22.
    View in: PubMed
    Score: 0.021
  33. The disconnect between phase II and phase III trials of drugs for heart failure. Nat Rev Cardiol. 2013 Feb; 10(2):85-97.
    View in: PubMed
    Score: 0.021
  34. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. J Am Coll Cardiol. 2013 Feb 05; 61(5):571-9.
    View in: PubMed
    Score: 0.021
  35. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial. Am Heart J. 2012 Dec; 164(6):884-92.e2.
    View in: PubMed
    Score: 0.021
  36. Parent-assisted or nurse-assisted epidural analgesia: is this feasible in pediatric patients? Paediatr Anaesth. 2009 Nov; 19(11):1084-9.
    View in: PubMed
    Score: 0.017
  37. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72.
    View in: PubMed
    Score: 0.016

© 2024 Kaiser Permanente